AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
Go back to AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec| AbbVie (NYSE: ABBV) | Delayed: 230.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $230.01 | 52 Week Low | $50.71 | |||
| Day High | $230.01 | P/E | 49.89 | |||
| Day Low | $230.01 | EPS | $4.61 | |||
| Volume | 18,347 | |||||

